NCT07366970 Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D?
| NCT ID | NCT07366970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Diabetes Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-12-05 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-12-05 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important
Eligibility Criteria
Inclusion Criteria: * diabetic men (forty) * type 2 diabetes * complaint of erectile dysfucntion (chronic complaint more than 24 months) * men with low vitamin D (deiciency in vitamin D) Exclusion Criteria: * cardiac patients * respiratory disease patients * renal disease * liver disease
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07366970 clinical trial?
This trial is open to male participants only, aged 35 Years or older, up to 45 Years, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07366970 currently recruiting?
Yes, NCT07366970 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07366970 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT07366970 clinical trial?
NCT07366970 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.